Ignite Creation Date:
2025-12-26 @ 10:19 PM
Ignite Modification Date:
2025-12-26 @ 10:19 PM
Study NCT ID:
NCT04584112
Status:
COMPLETED
Last Update Posted:
2023-03-15
First Post:
2020-10-05
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-28
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-08
Completion Date Type:
ACTUAL
First Submit Date:
2020-10-05
First Submit QC Date:
None
Study First Post Date:
2020-10-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-13
Last Update Post Date:
2023-03-15
Last Update Post Date Type:
ACTUAL